Evaluation of Satisfaction Regarding Patient's Management of Ocular Surface Diseases

Summary

Multicentric study, open label, uncontrolled phase IV in 140 patients with meibomian glands dysfunction .

Its objective is to Collect information from patients and ophthalmologists specialized in ocular surface and eyelids to anticipate how Blephasteam ® can be optimized.

This study involves 2 visits, visit of Inclusion, J0, then end of study visit, D21.

Between the two visits patients will be treated with Blephasteam ® for 21 days (up to two uses per day) and complete a questionnaire every two days during the first week and then once a week the next two weeks.

Conditions

• Eyelid Diseases

Interventions

DEVICE

Blephasteam

Eye lid warming goggles

Sponsors & Collaborators

• Laboratoires Thea

  lead INDUSTRY

Principal Investigators

• Jean Paul ADENIS, Professor · Hopital Dupuytren Limoges

• Isabelle BADELLON, Doctor · Fondation Rothschild Paris

• Vincent BORDERIE, Professor · CHNO des quinze-vingts

• Tristan BOURCIER, Professor · CHU de Strasbourg

• Jean Louis BOURGES, Doctor · Hotel Dieu Paris

• Dominique BREMOND GIGNAC, Professor · Centre Hospitalier Universitaire, Amiens

• Carole BURILLON, Professor · Hopital Edouard Heriot Lyon

• Philippe CAZEMIND, Doctor · Clinique du cours Dillion

• Hervé CHENAL, Doctor

• Joseph COLIN, Professor · University Hospital, Bordeaux

• Catherine CREUZOT GARCHER, Professor · Centre Hospitalier Universitaire Dijon

• Stephan FAUQUIER, Doctor

• Denis FLORES, Doctor

• Philippe GAIN, Professor · CHU de Saint Etienne

• Olivier Galatoire, Doctor · Fondation Rothschild Paris

• Damien GATINEL, Doctor · Fondation Rothschild Paris

• Jean Luc GEORGES, Professor · Central Hospital, Nancy, France

• Thanh HOANG XUAN, Professor

• Philippe IMBERT, Doctor · Polyclinique du Parc

• Marc LABETOULLE, Professor · CH de Bicetre

• Karim LAOUAR, Doctor · Centre Hospitalier de Nimes

• Sylvie MAES CASTELLARIN, Doctor · Hopital de Tarbes

• Sylvie MAINGUY, Doctor

• Claire MEURIOT TUIL, Doctor

• Solange MILAZZO, Professor · Centre Hospitalier Universitaire, Amiens

• Bruno MORTEMOUSQUE, Doctor · University Hospital, Bordeaux

• Pierre Jean PISELLA, Professor · CHU de Tours

• Pierre Yves ROBERT, Professor · University Hospital, Limoges

• Stephane RONCIN, Doctor · Polyclinique Saint Laurent

• Jean François ROULAND, Professor · CHU de Lille

• Pierre LABALETTE, Professor · CHU de Lille

• Frank ROUX, Doctor · HIA Laveran

• Claude SPEEG, ¨Professor · CHU de Strasbourg

• Michel TAZARTES, Doctor

• Yves UTEZA, Doctor

• Hatem ZEGHIDI, Doctor

• Benoit BRIAT, Doctor

Study Design

Allocation

NA

Purpose

TREATMENT

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

4 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2010-06-30

Primary Completion

2011-12-31

Completion

2011-12-31

Countries

• France

Study Locations